# The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color

> **NCT03402893** · PHASE4 · COMPLETED · sponsor: **Derm Research, PLLC** · enrollment: 21 (actual)

## Conditions studied

- Acne Vulgaris
- Post Inflammatory Hyperpigmentation

## Interventions

- **DRUG:** ONEXTON Topical Gel

## Key facts

- **NCT ID:** NCT03402893
- **Lead sponsor:** Derm Research, PLLC
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-28
- **Primary completion:** 2017-11-15
- **Final completion:** 2018-02-28
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2019-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03402893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03402893, "The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03402893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*